4.3 Article

No evidence of a significant role for CTLA-4 in multiple sclerosis

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 171, Issue 1-2, Pages 193-197

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2005.10.006

Keywords

multiple sclerosis; cytotoxic T-lymphocyte-associated protein 4; CTLA-4; genetic association; disease severity

Funding

  1. Wellcome Trust Funding Source: Medline

Ask authors/readers for more resources

Variation in the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene plays a significant role in determining susceptibility to autoimmune thyroid disease and type 1 diabetes. Its role in multiple sclerosis is more controversial. In order to explore this logical candidate more thoroughly, we genotyped 771 multiple sclerosis trio families from the United Kingdom for the 3' untranslated region variable number tandem repeat, the CT60 single nucleotide polymorphism (SNP) and five haplotype-tagging SNPs. No individual marker or common haplotype showed evidence of association with disease. These data suggest that any effect of CTLA-4 on multiple sclerosis susceptibility is likely to be very small. (c) 2005 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available